LivaNova PLC (LIVN) Key Metrics

NASDAQ: LIVNValuation, returns, debt and efficiency ratios over 10 years.

LIVN valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$4.26B
Enterprise value
$4.09B
P/E (TTM)
23.0
Forward P/E
16.0
PEG ratio
0.93
Price / sales
2.9
10-yr median 3.1
Price / book
3.2
10-yr median 2.5
EV / EBITDA
20.0
10-yr median 30.3
Dividend yield
—
Beta
0.88

LIVN key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

LIVN valuation Price multiples at each fiscal year-end price.

Price / sales+19.8%
2.4
2025 · hover or tap a bar for each year
2016: 1.8 (−66.6%)2017: 3.8 (+111.4%)2018: 4.0 (+4.7%)2019: 3.4 (−16.1%)2020: 3.4 (+2.4%)2021: 4.3 (+24.2%)2022: 2.9 (−32.0%)2023: 2.4 (−16.4%)2024: 2.0 (−17.1%)2025: 2.4 (+19.8%)
20162025
Price / book+46.0%
2.8
2025 · hover or tap a bar for each year
2016: 1.3 (+47.6%)2017: 2.1 (+65.7%)2018: 3.0 (+38.2%)2019: 2.6 (−10.7%)2020: 2.9 (+10.0%)2021: 3.4 (+17.9%)2022: 2.5 (−28.0%)2023: 2.2 (−10.8%)2024: 1.9 (−12.8%)2025: 2.8 (+46.0%)
20162025
Price / free cash flow+4.1%
19.4
2025 · hover or tap a bar for each year
2016: 41.5 (+91.6%)2017: 67.8 (+63.3%)2018: 53.8 (−20.7%)2021: 57.42022: 68.5 (+19.2%)2023: 70.2 (+2.6%)2024: 18.6 (−73.5%)2025: 19.4 (+4.1%)
20162025
Free cash flow yield−0.2 pts
5.2%
2025 · hover or tap a bar for each year
2016: 2.4% (−2.2 pts)2017: 1.5% (−0.9 pts)2018: 1.9% (+0.4 pts)2019: −3.2% (−5.0 pts)2020: −3.6% (−0.4 pts)2021: 1.7% (+5.3 pts)2022: 1.5% (−0.3 pts)2023: 1.4% (0.0 pts)2024: 5.4% (+4.0 pts)2025: 5.2% (−0.2 pts)
20162025

LIVN valuation history

Fiscal year-endToday10-year median

LIVN returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

LIVN debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

LIVN cash returned to shareholders

DividendsBuybacksFree cash flow

LIVN price vs earnings per share

Share price at year-endEPS (right axis)

LIVN key metrics

2016–2025
LivaNova PLC key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$3.35B$2.53B$2.80B$2.97B$4.43B$3.22B$3.65B$4.44B$3.88B$2.20B
Enterprise value$3.19B$2.78B$3.18B$3.34B$4.51B$3.67B$3.98B$4.56B$3.93B$2.28B
P/E ratio—40.0159.9———————
Price / sales2.42.02.42.94.33.43.44.03.81.8
Price / book2.81.92.22.53.42.92.63.02.11.3
Price / free cash flow19.418.670.268.557.4——53.867.841.5
Price / operating cash flow13.213.837.442.543.2——36.842.524.4
EV / sales2.32.22.83.34.43.93.74.13.91.9
EV / EBITDA—13.782.6108.0—180.730.3—19.718.8
EV / free cash flow18.420.479.676.958.5——55.268.743.1
Earnings yield−7.2%2.5%0.6%−2.9%−3.1%−10.8%−4.3%−4.3%−0.6%−2.9%
Free cash flow yield5.2%5.4%1.4%1.5%1.7%−3.6%−3.2%1.9%1.5%2.4%
Dividend yield——————0.1%—0.0%0.0%
Shareholder yield (dividends + buybacks)0.1%0.3%0.3%0.3%0.3%0.2%0.3%1.4%0.1%2.5%
Share price at fiscal year-end$61.53$46.31$51.74$55.54$87.43$66.21$75.43$91.47$79.92$44.97
Per share
Revenue per share$25.47$22.97$21.28$19.10$20.45$19.23$22.42$22.83$20.87$24.82
Earnings per share−$4.45$1.16$0.32−$1.61−$2.68−$7.18−$3.26−$3.91−$0.52−$1.28
Operating cash flow per share$4.67$3.35$1.38$1.31$2.03−$1.63−$1.89$2.48$1.88$1.84
Free cash flow per share$3.18$2.49$0.74$0.81$1.52−$2.35−$2.40$1.70$1.18$1.08
Cash per share$11.66$7.86$4.92$4.00$4.11$5.20$1.26$0.97$1.93$0.81
Book value per share$22.02$24.19$23.57$22.57$25.57$22.83$28.62$31.01$37.43$34.91
Tangible book value per share$3.25$6.10$4.31$1.31−$0.09−$5.16−$2.89−$4.61$10.22$8.30
Dividends per share——————$0.10—$0.00$0.00
Capex per share$1.49$0.86$0.65$0.50$0.50$0.72$0.51$0.78$0.70$0.76
Debt per share$8.68$12.40$11.81$10.85$5.66$14.59$8.17$3.47$3.01$2.51
Shares outstanding54.5M54.6M54.2M53.5M50.6M48.6M48.3M48.5M48.5M48.9M
Change in shares outstanding−0.1%+0.7%+1.3%+5.7%+4.2%+0.5%−0.3%−0.0%−0.8%+83.7%
Returns & profitability
Return on equity (ROE)−19.2%4.9%1.4%−6.9%−11.3%−28.0%−10.9%−11.4%−1.4%−3.6%
Return on invested capital (ROIC)12.1%5.7%−3.4%−4.1%−0.0%−13.2%−8.1%−11.2%3.1%−1.2%
Return on assets (ROA)−9.5%2.6%0.7%−3.8%−5.9%−14.5%−6.4%−7.5%−1.0%−2.6%
Return on tangible assets−15.3%4.2%1.3%−7.5%−15.1%−33.5%−17.7%−23.0%−2.1%−6.0%
Free cash flow margin12.5%10.8%3.5%4.2%7.4%−12.2%−10.7%7.5%5.7%4.4%
Income quality (OCF / net income)—2.894.27———————
Financial health
Total debt$473.3M$676.8M$640.4M$580.4M$286.7M$709.1M$394.9M$168.3M$146.0M$122.9M
Cash & short-term investments$635.6M$428.9M$266.5M$214.2M$208.0M$252.8M$61.1M$47.2M$93.6M$39.8M
Net debt−$162.3M$247.9M$373.9M$366.3M$78.7M$456.3M$333.7M$121.1M$52.4M$83.1M
Debt / equity0.390.510.500.480.220.640.290.110.080.07
Debt / assets0.180.270.260.250.130.300.160.070.060.05
Net debt / EBITDA—1.229.7211.85—22.452.54—0.260.69
Current ratio1.362.872.952.980.972.291.071.072.141.96
Quick ratio1.162.502.512.540.821.920.750.761.791.38
Interest coverage4.02.0-1.2-1.6-0.0-6.7-11.4-25.312.3-2.6
Working capital$293.5M$735.1M$653.2M$588.7M−$17.8M$399.0M$36.9M$36.6M$463.9M$303.3M
Invested capital$1.04B$1.57B$1.65B$1.57B$1.37B$1.57B$1.72B$1.62B$1.87B$1.79B
Tangible asset value$177.2M$333.0M$233.5M$70.3M−$4.6M−$250.7M−$139.6M−$223.5M$495.7M$406.0M
Net current asset value−$304.5M−$58.9M−$163.8M−$201.0M−$227.1M−$582.7M−$478.6M−$512.7M$181.3M−$15.6M
Graham number—$25.11$13.10———————
Graham net-net per share−$9.65−$9.45−$11.99−$12.10−$9.44−$17.31−$14.29−$15.05−$6.35−$6.08
Capital allocation
Dividends paid——————$4.8M—$0$0
Share buybacks (net)$4.4M$8.4M$7.5M$8.7M$12.9M$5.6M$7.1M$61.6M$4.1M$54.8M
Dividends + buybacks / free cash flow2.6%6.2%18.8%20.0%16.8%——74.7%7.1%103.3%
Capex / revenue5.8%3.8%3.0%2.6%2.5%3.7%2.3%3.4%3.4%3.1%
Capex / operating cash flow31.9%25.7%46.7%37.9%24.8%——31.5%37.3%41.2%
Capex / depreciation1.930.920.570.460.370.430.300.540.490.44
Stock-based compensation / revenue2.6%2.7%3.2%4.4%3.9%3.8%3.0%2.4%1.9%1.6%
R&D / revenue13.4%14.6%16.8%15.2%17.7%16.4%18.2%13.2%10.8%10.1%
SG&A / revenue39.5%42.0%43.7%45.9%45.6%45.8%46.7%41.8%37.8%29.4%
Efficiency
Days sales outstanding57.863.968.078.271.986.686.689.4101.382.4
Days of inventory on hand127.1140.9132.4136.5122.5150.2160.9146.0166.0141.8
Days payables outstanding68.071.874.182.678.585.882.379.790.572.6
Cash conversion cycle (days)117.0133.0126.3132.1116.0151.1165.1155.7176.7151.7
Receivables turnover6.315.715.374.675.074.214.214.083.604.43
Payables turnover5.375.084.934.424.654.264.434.584.035.03
Inventory turnover2.872.592.762.672.982.432.272.502.202.57
Asset turnover0.540.510.490.450.450.390.440.440.420.50
Average receivables$219.9M$219.4M$214.9M$218.9M$204.1M$221.8M$257.2M$271.2M$281.0M$274.0M
Average payables$83.5M$75.3M$77.6M$71.2M$70.8M$79.8M$81.3M$81.3M$89.5M$101.3M
Average inventory$156.1M$147.7M$138.6M$117.6M$110.6M$139.7M$158.8M$149.0M$164.0M$198.0M
Intangibles / total assets39.2%39.4%43.0%49.6%59.0%56.7%63.2%67.7%52.7%55.5%

Computed from LIVN's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

LIVN valuation and financial ratios

Based on the latest twelve months, the trailing P/E is 23.0 and the forward P/E is 16.0. LivaNova earned a return on equity of −19.2% and a return on invested capital of 12.1% in fiscal 2025. It ended the year with $473.3 million of debt and $635.6 million in cash and short-term investments, a net cash position of $162.3 million. It returned $4.4 million to shareholders: $0 in dividends and $4.4 million in share buybacks, 3% of free cash flow. The share count rose 11.5% from 48.9M to 54.5M over 9 years.

See the LIVN income statement, the LIVN chart for price history, or the LIVN stock overview for the latest quote and news.

LIVN key metrics FAQ

What is LivaNova's P/E ratio?

LivaNova's trailing P/E ratio is 23.0 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 16.0. At the end of fiscal 2025 it was —.

What is LivaNova's return on equity?

LivaNova's return on equity (ROE) was −19.2% in fiscal 2025: net income of -$242.5 million on average shareholders' equity of $1.3 billion.

What is LivaNova's ROIC?

LivaNova's return on invested capital was 12.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does LivaNova have?

LivaNova had total debt of $473.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.39 and more cash than debt.

Does LivaNova buy back its shares?

Yes. LivaNova spent $4.4 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.1% over the year, to 54.5M..

What is LivaNova's free cash flow yield?

LivaNova generated $173.2 million of free cash flow in fiscal 2025, a free cash flow yield of 5.2% on its market value at year-end ($3.4 billion).

What is LivaNova's current ratio?

LivaNova's current ratio was 1.36 at the end of fiscal 2025: current assets were 1.36 times current liabilities.

Medical Devices key metrics